S&P 500   2,998.36 (+1.09%)
DOW   27,046.61 (+0.97%)
QQQ   193.37 (+1.19%)
AAPL   235.62 (-0.11%)
FB   189.77 (+3.54%)
MSFT   141.38 (+1.31%)
AMZN   1,758.54 (+1.27%)
CGC   19.88 (+5.41%)
NVDA   196.85 (+5.53%)
MU   46.29 (+3.19%)
AMD   30.64 (+0.36%)
T   37.90 (+1.15%)
ACB   3.75 (+6.83%)
GILD   65.51 (+1.55%)
S&P 500   2,998.36 (+1.09%)
DOW   27,046.61 (+0.97%)
QQQ   193.37 (+1.19%)
AAPL   235.62 (-0.11%)
FB   189.77 (+3.54%)
MSFT   141.38 (+1.31%)
AMZN   1,758.54 (+1.27%)
CGC   19.88 (+5.41%)
NVDA   196.85 (+5.53%)
MU   46.29 (+3.19%)
AMD   30.64 (+0.36%)
T   37.90 (+1.15%)
ACB   3.75 (+6.83%)
GILD   65.51 (+1.55%)
Log in

Senseonics Stock Price, News & Analysis (NYSEAMERICAN:SENS)

$0.93
+0.10 (+12.05 %)
(As of 10/15/2019 12:03 PM ET)
Today's Range
$0.88
Now: $0.93
$0.95
50-Day Range
$0.97
MA: $1.07
$1.17
52-Week Range
$0.80
Now: $0.93
$4.15
Volume924,265 shs
Average Volume1.74 million shs
Market Capitalization$188.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:SENS
Previous SymbolNASDAQ:SENS
CUSIPN/A
CIKN/A
Phone+1-301-5157260

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees192
Market Cap$188.95 million
Next Earnings Date11/14/2019 (Estimated)
OptionableOptionable

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.


Senseonics (NYSEAMERICAN:SENS) Frequently Asked Questions

What is Senseonics' stock symbol?

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

How were Senseonics' earnings last quarter?

Senseonics Holdings Inc (NYSEAMERICAN:SENS) released its quarterly earnings data on Wednesday, August, 7th. The company reported ($0.17) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.16) by $0.01. The business had revenue of $4.61 million for the quarter, compared to analyst estimates of $4.52 million. View Senseonics' Earnings History.

When is Senseonics' next earnings date?

Senseonics is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for Senseonics.

What guidance has Senseonics issued on next quarter's earnings?

Senseonics updated its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $25-30 million, compared to the consensus revenue estimate of $26.36 million.

What price target have analysts set for SENS?

4 brokers have issued 1 year price objectives for Senseonics' shares. Their predictions range from $2.00 to $2.00. On average, they expect Senseonics' share price to reach $2.00 in the next year. This suggests a possible upside of 115.1% from the stock's current price. View Analyst Price Targets for Senseonics.

What is the consensus analysts' recommendation for Senseonics?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Senseonics.

Has Senseonics been receiving favorable news coverage?

Media stories about SENS stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research group rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Senseonics earned a news impact score of 1.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Senseonics.

Are investors shorting Senseonics?

Senseonics saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 38,320,000 shares, an increase of 5.7% from the August 30th total of 36,250,000 shares. Based on an average daily trading volume, of 2,010,000 shares, the short-interest ratio is presently 19.1 days. Approximately 33.6% of the shares of the stock are short sold. View Senseonics' Current Options Chain.

Who are some of Senseonics' key competitors?

What other stocks do shareholders of Senseonics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC), CytoDyn (CYDY), Tandem Diabetes Care (TNDM), TransEnterix (TRXC), Sorrento Therapeutics (SRNE), Tetraphase Pharmaceuticals (TTPH), Novavax (NVAX), NVIDIA (NVDA), Rigel Pharmaceuticals (RIGL) and Advanced Micro Devices (AMD).

Who are Senseonics' key executives?

Senseonics' management team includes the folowing people:
  • Dr. Timothy T. Goodnow, Pres, CEO & Director (Age 57)
  • Dr. Mukul Jain, Chief Operating Officer (Age 46)
  • Mr. Jon D. Isaacson, Chief Financial Officer
  • Dr. Francine Ratner Kaufman, Chief Medical Officer
  • Ms. Mirasol G. Panlilio, VP & Gen. Mang. of Global Commercial Operations (Age 54)

Who are Senseonics' major shareholders?

Senseonics' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Canton Hathaway LLC (0.02%). Company insiders that own Senseonics stock include Douglas A Roeder, Mukul Jain, Peter J Barris and Timothy T Goodnow. View Institutional Ownership Trends for Senseonics.

Which major investors are selling Senseonics stock?

SENS stock was sold by a variety of institutional investors in the last quarter, including Canton Hathaway LLC. View Insider Buying and Selling for Senseonics.

How do I buy shares of Senseonics?

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Senseonics' stock price today?

One share of SENS stock can currently be purchased for approximately $0.93.

How big of a company is Senseonics?

Senseonics has a market capitalization of $188.95 million. Senseonics employs 192 workers across the globe.View Additional Information About Senseonics.

What is Senseonics' official website?

The official website for Senseonics is http://www.senseonics.com/.

How can I contact Senseonics?

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.


MarketBeat Community Rating for Senseonics (NYSEAMERICAN SENS)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  204 (Vote Outperform)
Underperform Votes:  164 (Vote Underperform)
Total Votes:  368
MarketBeat's community ratings are surveys of what our community members think about Senseonics and other stocks. Vote "Outperform" if you believe SENS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SENS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Featured Article: Support Level

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel